Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies announced that the Combined General Meeting (ordinary and extraordinary sessions) of Transgene’s shareholders will be held on May 22, 2019, at 10 a.m. at the Company’s registered office